Prolonged Glycation of Hen Egg White Lysozyme Generates Non Amyloidal Structures

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ghosh, Sudeshna ^a   Pandey, Nitin Kumar ^a   Singha Roy, Atanu ^a   Tripathy, Debi Ranjan ^a   Dinda, Amit Kumar ^a   Dasgupta, Swagata ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; FRUCTOSE; GLUCOSE; HEN EGG WHITE LYSOZYME; LYSOZYME; OLIGOMER; RIBOSE; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME DEFECT; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; HEN; MICROSCOPY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STEADY STATE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; GLUCOSE; GLYCOSYLATION; MURAMIDASE; RIBOSE;

EID: 84884181426     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074336     Document Type: Article

References (65)

1. Cloos PAC, Christgau S, (2002) Non-enzymatic covalent modifications of proteins: mechanisms, physiological consequences and clinical applications. Matrix Biol 21: 39-52. doi:10.1016/S0945-053X(01)00188-3. PubMed: 11827791.
2. Lapolla A, Traldi P, Fedele D, (2005) Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 38: 103-115. doi:10.1016/j.clinbiochem.2004.09.007. PubMed: 15642271.
3. Brownlee M, (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234. doi:10.1146/annurev.med.46.1.223. PubMed: 7598459.
4. Bouma B, Kroon-Batenburg LMJ, Wu YP, Brünjes B, Posthuma G, et al. (2003) Glycation induces formation of amyloid cross-β structure in albumin. J Biol Chem 278: 41810-41819. doi:10.1074/jbc.M303925200. PubMed: 12909637.
5. Chevalier F, Chobert JM, Dalgalarrondo M, Choiset Y, Haertlé T, (2002) Maillard glycation of beta-lactoglobulin induces conformation changes. Nahrung 46: 58-63. doi:10.1002/1521-3803(20020301)46:2. PubMed: 12017991.
6. Jackson GS, Clarke AR, (2000) Mammalian prion proteins. Curr Opin Struct Biol 10: 69-74. doi:10.1016/S0959-440X(99)00051-2. PubMed: 10679460.
7. Tan SY, Pepys MB, (1994) Amyloidosis. Histopathology 25: 403-414. doi:10.1111/j.1365-2559.1994.tb00001.x. PubMed: 7868080.
8. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, et al. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 91: 4766-4770. doi:10.1073/pnas.91.11.4766. PubMed: 8197133.
9. Sasaki N, Takeuchi M, Chowei H, Kikuchi S, Hayashi Y, et al. (2002) Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci Lett 326: 117-120. doi:10.1016/S0304-3940(02)00310-5. PubMed: 12057842.
10. Kapurniotu A, Bernhagen J, Greenfield N, Al-Abed Y, Teichberg S, et al. (1998) Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide. Eur J Biochem 251: 208-216. doi:10.1046/j.1432-1327.1998.2510208.x. PubMed: 9492286.
11. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, et al. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273: 729-739. doi:10.1006/jmbi.1997.1348. PubMed: 9356260.
12. Li XH, Du LL, Cheng XS, Jiang X, Zhang Y, et al. (2013) Glycation exacerbates the neuronal toxicity of β-amyloid. Cell Death Dis 4: e673.
13. Blake CCF, Koenig DF, Mair GA, North ACT, Phillips DC, et al. (1965) Structure of hen egg-white lysozyme. A three-dimensional Fourier synthesis at 2 Angstrom resolution. Nature 206: 757-761. doi:10.1038/206757a0. PubMed: 5891407.
14. Dobson CM, Evans PA, Radford SE, (1994) Understanding how proteins fold: the lysozyme story so far. Trends Biochem Sci 19: 31-37. doi:10.1016/0968-0004(94)90171-6. PubMed: 8140619.
15. Arnaudov LN, de Vries R, (2005) Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophys J 88: 515-526. doi:10.1529/biophysj.104.048819. PubMed: 15489299.
16. Mishra R, Sörgjerd K, Nyström S, Nordigården A, Yu YC, et al. (2007) Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. J Mol Biol 366: 1029-1044. doi:10.1016/j.jmb.2006.11.084. PubMed: 17196616.
17. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, et al. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362: 553-557. doi:10.1038/362553a0. PubMed: 8464497.
18. Morozova-Roche LA, Zurdo J, Spencer A, Noppe W, Receveur V, et al. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J Struct Biol 130: 339-351. doi:10.1006/jsbi.2000.4264. PubMed: 10940237.
19. Arnaudov LN, de Vries R, (2005) Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophys J 88: 515-526. doi:10.1529/biophysj.104.048819. PubMed: 15489299.
20. Gustot A, Raussens V, Dehousse M, Dumoulin M, Bryant CE, et al. (2013) Activation of innate immunity by lysozyme fibrils is critically dependent on cross-β sheet structure. Cell Mol Life Sci 70: 2999-3012. doi:10.1007/s00018-012-1245-5. PubMed: 23334185.
21. Chaudhary N, Nagaraj R, (2009) Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles. Mol Cell Biochem 328: 209-215. doi:10.1007/s11010-009-0091-8. PubMed: 19322639.
22. Gharibyan AL, Zamotin V, Yanamandra K, Moskaleva OS, Margulis BA, et al. (2007) Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. J Mol Biol 365: 1337-1349. doi:10.1016/j.jmb.2006.10.101. PubMed: 17134716.
23. Tagami U, Akashi S, Mizukoshi T, Suzuki E, Hirayama K, (2000) Structural studies of the Maillard reaction products of a protein using ion trap mass spectrometry. J Mass Spectrom 35: 131-138. doi:10.1002/(SICI)1096-9888(200002)35:2. PubMed: 10679972.
24. Lapolla A, Fedele D, Aronica R, Baldo L, D'Alpaos M, et al. (1996) The in vitro glycation of lysozyme and the influence of buffer concentration investigated by mass spectrometry. Rapid Commun Mass Spectrom 10: 1512-1518. doi:10.1002/(SICI)1097-0231(199609)10:12. PubMed: 8885421.
25. Bathaie SZ, Nobakht BB, Mirmiranpour H, Jafarnejad A, Moosavi-Nejad SZ, (2011) Effect of chemical chaperones on glucose-induced lysozyme modifications. Proteins J 30: 480-489. doi:10.1007/s10930-011-9353-x. PubMed: 21882049.
26. López-Jaramillo FJ, Pérez-Banderas F, Hernández-Mateo F, Santoyo-González F, (2005) Production, crystallization and X-ray characterization of chemically glycosylated hen egg-white lysozyme. Acta Crystallogr Sect Struct Biol Cryst Commun 61: 435-438. doi:10.1107/S0108768105015004. PubMed: 16511062.
27. Yeboah FK, Alli I, Yaylayan VA, Konishi Y, Stefanowicz P, (2000) Monitoring glycation of lysozyme by electrospray ionization mass spectrometry. J Agric Food Chem 48: 2766-2774. doi:10.1021/jf990978j. PubMed: 10898620.
28. Seo S, Karboune S, L'Hocine L, Yaylayan V, (2013) Characterization of glycated lysozyme with galactose, galactooligosaccharides and galactan: effect of glycation on structural and functional properties of conjugates. Food Sci Technol 53: 44-53.
29. Muthenna P, Akileshwari C, Reddy GB, (2012) Ellagic acid, a new antiglycating agent: its inhibition of Nε{lunate}-(carboxymethyl)lysine. Biochem J 442: 221-230.
30. Zheng F, Cai W, Mitsuhashi T, Vlassara H, (2001) Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy? Mol Med 7: 737-747. PubMed: 11788787.
31. Sattarahmady N, Moosavi-Movahedi AA, Habibi-Rezaei M, Ahmadian S, Saboury AA, et al. (2008) Detergency effects of nanofibrillar amyloid formation on glycation of human serum albumin. Carbohydr Res 343: 2229-2234. doi:10.1016/j.carres.2008.04.036. PubMed: 18513709.
32. Wei Y, Chen L, Chen J, Ge L, He RQ, (2009) Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells. BMC Cell Biol 10: 10. doi:10.1186/1471-2121-10-10. PubMed: 19216769.
33. Wei Y, Han CS, Zhou J, Liu Y, Chen L, et al. (2012) D-ribose in glycation and protein aggregation. Biochim Biophys Acta 1820: 488-494. doi:10.1016/j.bbagen.2012.01.005. PubMed: 22274132.
34. Chen L, Wei Y, Wang X, He R, (2009) D-Ribosylated tau forms globular aggregates with high cytotoxicity. Cell Mol Life Sci 66: 2559-2571. doi:10.1007/s00018-009-0058-7. PubMed: 19517062.
35. Chen L, Wei Y, Wang X, He R, (2010) Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products. PLOS ONE 5: e9052. doi:10.1371/journal.pone.0009052. PubMed: 20140223.
36. Kong FL, Cheng W, Chen J, Liang Y, (2011) D-Ribose glycates β(2)-microglobulin to form aggregates with high cytotoxicity through a ROS-mediated pathway. Chem Biol Interact 194: 69-78. doi:10.1016/j.cbi.2011.08.003. PubMed: 21864514.
37. Seneff S, Wainwright G, Mascitelli L, (2011) Nutrition and Alzheimer's disease: the detrimental role of a high carbohydrate diet. Eur J Intern Med 22: 134-140. doi:10.1016/j.ejim.2010.12.017. PubMed: 21402242.
38. Khan TA, Saleemuddin M, Naeem A, (2011) Partially folded glycated state of human serum albumin tends to aggregate. Int J Pept Res Ther 17: 271-279. doi:10.1007/s10989-011-9267-7.
39. Saurabh S, Sahoo PK, (2008) Lysozyme: an important defence molecule of fish innate immune system. Aquacult Res 39: 223-239. doi:10.1111/j.1365-2109.2007.01883.x.
40. Ganz T, (2004) Antimicrobial polypeptides. J Leukoc Biol 75: 34-38. PubMed: 12960278.
41. Oliveira LM, Lages A, Gomes RA, Neves H, Família C, et al. (2011) Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation. BMC Biochem 12: 41. doi:10.1186/1471-2091-12-41. PubMed: 21819598.
42. Oliveira LM, Gomes RA, Yang D, Dennison SR, Família C, et al. (2013) Insights into the molecular mechanism of protein native-like aggregation upon glycation. Biochim Biophys Acta 1834: 1010-1022. doi:10.1016/j.bbapap.2012.12.001. PubMed: 23228929.
43. Pace CN, Vajdos F, Fee L, Grimsley G, Gray T, (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4: 2411-2423. doi:10.1002/pro.5560041120. PubMed: 8563639.
44. Ahmed N, Furth AJ, (1992) Failure of common glycation assays to detect glycation by fructose. Clin Chem 38: 1301-1303. PubMed: 1623595.
45. Handl M, Filová E, Kubala M, Lánský Z, Kolácná L, et al. (2007) Fluorescent advanced glycation end products in the detection of factual stages of cartilage degeneration. Physiol Res 56: 235-242. PubMed: 16555949.
46. Yamamoto Y, Sakata N, Meng J, Sakamoto M, Noma A, et al. (2002) Possible involvement of increased glycoxidation and lipid peroxidation of elastin in atherogenesis in haemodialysis patients. Nephrol Dial Transplant 17: 630-636. doi:10.1093/ndt/17.4.630. PubMed: 11917057.
47. Vo-Dinh T, (1982) Synchronous luminescence spectroscopy: methodology and applicability. Appl Spectrosc 36: 576-581. doi:10.1366/0003702824639510.
48. Whitmore L, Wallace BA, (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32: W668-W673. doi:10.1093/nar/gkh371. PubMed: 15215473.
49. Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, et al. (2001) Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 276: 12292-12300. doi:10.1074/jbc.M007822200. PubMed: 11116141.
50. Roth Z, Yehezkel G, Khalaila I, (2012) Identification and quantification of protein glycosylation. Int J Carbohyd Chem(2012): pp. 1-10.
51. Naiki H, Higuchi K, Hosokawa M, Takeda T, (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 177: 244-249. doi:10.1016/0003-2697(89)90046-8. PubMed: 2729542.
52. Biancalana M, Makabe K, Koide A, Koide S, (2009) Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies. J Mol Biol 385: 1052-1063. doi:10.1016/j.jmb.2008.11.006. PubMed: 19038267.
53. Kikuchi S, Shinpo K, Takeuchi M, Yamagishi S, Makita Z, et al. (2003) Glycation: a sweet tempter for neuronal death. Brain Res Brain. Res Rev 41: 306-323. doi:10.1016/S0165-0173(02)00273-4.
54. Coussons PJ, Jacoby J, McKay A, Kelly SM, Price NC, et al. (1997) Glucose modification of human serum albumin: a structural study. Free Radic Biol Med 22: 1217-1227. doi:10.1016/S0891-5849(96)00557-6. PubMed: 9098096.
55. Luthra M, Balasubramanian D, (1993) Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins. J Biol Chem 268: 18119-18127. PubMed: 8349689.
56. Monnier VM, (1990) Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol 45: B105-B111. doi:10.1093/geronj/45.4.B105. PubMed: 2195101.
57. Harvey SC, Prabhakaran M, (1986) Ribose puckering: structure, dynamics, energetics, and the pseudorotation cycle. J Am Chem Soc 108: 6128-6136. doi:10.1021/ja00280a004.
58. Han C, Lu Y, Wei Y, Liu Y, He R, (2011) D-Ribose induces cellular protein glycation and impairs mouse spatial cognition. PLOS ONE 6: e24623. doi:10.1371/journal.pone.0024623. PubMed: 21966363.
59. Das BK, Sun TX, Akhtar NJ, Chylack LT Jr, Liang JJ, (1998) Fluorescence and immunochemical studies of advanced glycation-related lens pigments. Invest Ophthalmol Vis Sci 39: 2058-2066. PubMed: 9761284.
60. GhoshMoulick R, Bhattacharya J, Roy S, Basak S, Dasgupta AK, (2007) Compensatory secondary structure alterations in protein glycation. Biochim Biophys Acta 1774: 233-242. doi:10.1016/j.bbapap.2006.11.018. PubMed: 17234463.
61. Kirkitadze MD, Condron MM, Teplow DB, (2001) Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol 312: 1103-1119. doi:10.1006/jmbi.2001.4970. PubMed: 11580253.
62. Vaney MC, Maignan S, Riès-Kautt M, Ducriux A, (1996) High-resolution structure (1.33 A) of a HEW lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from SpaceHab-01 mission. Acta Crystallogr D Biol Crystallogr 52: 505-517. doi:10.1107/S090744499501674X. PubMed: 15299672.
63. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511. doi:10.1038/416507a. PubMed: 11932737.
64. Ishimaru D, Andrade LR, Teixeira LSP, Quesado PA, Maiolino LM, et al. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42: 9022-9027. doi:10.1021/bi034218k. PubMed: 12885235.
65. Wei Y, Han CS, Zhou J, Liu Y, Chen L, et al. (2012) D-ribose in glycation and protein aggregation. Biochim Biophys Acta 1820: 488-494. doi:10.1016/j.bbagen.2012.01.005. PubMed: 22274132.